Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
about
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501Retrospective analysis of Japanese patients with relapse or refractory small-cell lung cancer treated with amrubicin hydrochlorideEfficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.Lung cancer: current diagnosis and treatmentConsolidative thoracic radiotherapy for extensive stage small cell lung cancerMetabolic burden measured by (18)f-fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in patients with small cell lung cancerCognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.Tailoring to RB: tumour suppressor status and therapeutic response.The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developmentsFrequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by ion torrent DNA sequencing.Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.Relevance of an incidental chest finding.Small cell lung cancer: will recent progress lead to improved outcomes?Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.A decade of advances in treatment of early-stage lung cancer.A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded.Surgical outcomes in patients with small cell lung cancer: comparative analysis of computed tomograpy-detected patients with others.The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine CarcinomaPrognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.Adjuvant chemotherapy in resected lung cancer: two-year experience in a university hospital.Current role of surgery in small cell lung carcinomaImproved survival modeling in cancer research using a reduced piecewise exponential approach.Progress in the management of limited-stage small cell lung cancer.Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models.Update on new drugs in small cell lung cancer.Potential of CXCR4 antagonists for the treatment of metastatic lung cancer.Limited disease of extra-pulmonary small cell carcinoma. Impact of local treatment and nodal status, role of cranial irradiation.Management of small cell lung cancer: recent developments for optimal care.Prophylactic cranial irradiation for small-cell lung cancer: how, when and for whom?Uptake and tolerance of chemotherapy in elderly patients with small cell lung cancer and impact on survival.Huntingtin interacting protein 1 as a histopathologic adjunct in the diagnosis of Merkel cell carcinoma.Aggressive Palliation in Extensive Stage Small Cell Lung Cancer, Practice Guidelines versus Clinical Practice: A Case Report and Review of the Literature.Current challenges of lung cancer care in an aging population.The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.Genomic profiling of high-grade large-cell neuroendocrine carcinoma of the colon.Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosis.Experience with carboplatin and etoposide maintenance chemotherapy in patients with extensive stage small cell lung cancer.Bacterial pneumonia following cytotoxic chemotherapy for lung cancer: clinical features, treatment outcome and prognostic factors.
P2860
Q24658198-412BAB3F-8613-43A4-8783-02F5BD1DE0A4Q33403230-07A8238F-190D-48B9-B005-453CA27406DAQ33425887-53C9FB69-D164-4CDF-8916-E34E25A6D854Q33554085-F6B97CC1-20A0-4F59-8F7A-004ACDCE98E7Q33591894-24F0ADC8-FE09-484D-B53D-DF605522FA57Q33619243-93E81346-EF57-4A26-A5F8-656E810C017BQ34021952-56B390AE-D467-4CF5-A92F-E0D07BF0F1EEQ34040108-2533060C-6B4E-4D11-B283-FDD2AC2D3C03Q34202289-8683E901-CB14-4AE8-8003-0040AAA4DAFAQ35156166-6E7E4397-08A5-4C8F-BC24-71B6A7483E46Q35583915-0E0FFDAA-D26F-485A-9D16-8A29B8B8452BQ35746472-DB6A0F4D-202F-4189-8F31-F019DE051761Q35836257-5DB3E7A9-91C2-46FB-9F22-EBF22ACE453EQ35870332-FA385491-6197-49BB-A4E2-7CD7497DDF2DQ36111869-3061335F-1466-4BD0-82BE-95319318CE39Q36482519-16769EC5-D18D-4742-A4F7-292E108CEBBAQ36611813-615B54BA-72F6-438F-8538-DD4517367D02Q36691012-4FEBE62D-8266-4564-BF73-C9D4DB883053Q36805567-52DD81CD-3021-4C17-9335-17CC527D96E0Q37178855-443D3040-8144-4D92-BA43-3692E472AA0FQ37185492-D5F2537E-85DC-4F6B-A238-5E23ECEA8159Q37276658-E2B372B5-3A88-4EDA-9DCF-ABC947545809Q37554645-5C86E31A-FACE-4FE3-824A-6E7FED5132FDQ37626969-C1574CFA-4B97-4AC2-B844-2E1A4E05770BQ37673472-8B0D371A-1051-4309-BA1B-379452CF250EQ37698957-F1EF1788-AA36-486A-BC22-A5717D8219B0Q37851992-DC167544-95BF-4697-BD11-5D3C37D493E1Q37866794-F8502707-7FE6-4EF8-AE75-A54B7FDF1325Q37982266-7DCE2A36-209C-47A8-9F96-4E7CE35CF66CQ37987205-C339DAB7-D98D-4A69-9E5C-12128C4EEDE9Q38002472-77F8E2A8-744B-4493-A645-8284391CC01EQ38068403-F4C3597C-AE7D-4E62-94A5-6F266DF5A6B0Q38390744-5557132F-097E-4778-995C-E6DDF3F4D329Q38575747-0E750E13-2F7B-468D-91EC-3456890A0079Q38608627-AD441099-5FAB-4B4A-9CA4-F650F5BCA949Q38847321-499AA859-FB75-4D18-A903-16ABFE251341Q38859321-0E5CCAB6-C517-492E-BC19-E2E338943F0AQ38867420-FB2E362C-DE4D-4F59-A6BD-9D8F25DBD8F6Q42170500-54B51266-E280-44EC-8306-5D4E2F5B9AD3Q44707933-21E10C05-41A8-4990-A872-8EF5F6C80543
P2860
Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Management of small cell lung ...... ctice guidelines (2nd edition)
@ast
Management of small cell lung ...... ctice guidelines (2nd edition)
@en
Management of small cell lung ...... ctice guidelines (2nd edition)
@nl
type
label
Management of small cell lung ...... ctice guidelines (2nd edition)
@ast
Management of small cell lung ...... ctice guidelines (2nd edition)
@en
Management of small cell lung ...... ctice guidelines (2nd edition)
@nl
prefLabel
Management of small cell lung ...... ctice guidelines (2nd edition)
@ast
Management of small cell lung ...... ctice guidelines (2nd edition)
@en
Management of small cell lung ...... ctice guidelines (2nd edition)
@nl
P356
P1433
P1476
Management of small cell lung ...... ctice guidelines (2nd edition)
@en
P2093
Andrew Turrisi
George R Simon
P304
P356
10.1378/CHEST.07-1385
P407
P433
P577
2007-09-01T00:00:00Z